ArticleAntimicrobial agents and chemotherapy2015

Baseline activity of telavancin against Gram-positive clinical isolates responsible for documented infections in U.S. hospitals (2011-2012) as determined by the revised susceptibility testing method.

Rodrigo E Mendes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.